导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 5.57% | 362/1050 |
| 近一周 | -2.21% | 497/1104 |
| 近一月 | -3.75% | 451/1102 |
| 近一季 | -4.93% | 419/1092 |
| 近半年 | 0.82% | 403/1070 |
| 近一年 | 10.33% | 346/1018 |
| 近两年 | 78.46% | 298/926 |
| 近三年 | 41.91% | 313/834 |
| 成立以来 | 101.11% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.44% 519/1070 |
24.44% 341/1101 |
- - |
- - |
| 2025 | 38.49% 341/1065 |
2.62% 591/1014 |
2.50% 465/1038 |
30.18% 355/1050 |
1.14% 381/1065 |
| 2024 | 5.28% 415/1011 |
3.23% 157/960 |
-6.35% 711/983 |
11.00% 549/991 |
-1.89% 439/1011 |
| 2023 | -6.10% 229/952 |
4.92% 334/880 |
-0.67% 223/895 |
-2.45% 175/915 |
-7.64% 735/952 |
| 2022 | -11.71% 108/867 |
-10.32% 116/773 |
4.12% 575/806 |
-7.50% 121/845 |
2.22% 314/867 |
| 2021 | 10.55% 240/740 |
4.45% 54/580 |
5.52% 460/659 |
2.35% 181/704 |
-2.00% 511/740 |
| 2020 | 37.98% 309/554 |
-5.45% 304/419 |
14.18% 366/466 |
14.21% 158/517 |
11.90% 297/554 |
| 2019 | 30.10% 288/410 |
25.04% 700/1146 |
-4.25% 664/1228 |
0.86% 314/390 |
7.75% 247/410 |
| 2018 | - - |
- - |
- - |
-1.13% 248/1000 |
-11.28% 440/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 博时量化多策略股票C VS. 东吴新产业精选股票A(580008) |